Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards
Authors:
Open Access
- 9 July 2024
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 47 (11) , 1149-1156
Abstract
Background and Objectives Statistical methods for signal detection of adverse drug reactions (ADRs) in electronic health records (EHRs) need information about optimal significance levels and sample sizes to achieve sufficient power. Sauzet and Cornelius proposed tests for signal detection based on the hazard functions of Weibull type distributions (WSP tests) which use the time-to-event information available in EHRs. Optimal significance levels and sample sizes for the application of the WPS tests are derived. Method A simulation study was performed with a range of scenarios for sample size, rate of event due (ADRs), and not due to the drug and random time to ADR occurrence. Based on the area under the curve of the receiver operating characteristic graph, we obtain optimal significance levels of the different WSP tests for the implementation in a hypothesis free signal detection setting and approximate sample sizes required to reach a power of 80% or 90%. Results The dWSP–pPWSP (combination of double WSP and power WSP) test with a significance level of 0.004 was recommended. Sample sizes needed for a power of 80% were found to start at 60 events for an ADR rate equal to the background rate of 0.1. The number of events required for a background rate of 0.05 and an ADR rate equal to a 20% increase of the background rate was 900. Conclusion Based on this study, it is recommended to use the dWSP–pWSP test combination for signal detection with a significance level of 0.004 when the same test is applied to all adverse events not depending on rates.Keywords
Funding Information
- Universität Bielefeld
This publication has 18 references indexed in Scilit:
- An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health DataDrug Safety, 2019
- Machine learning model combining features from algorithms with different analytical methodologies to detect laboratory-event-related adverse drug reaction signalsPLOS ONE, 2018
- Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational DatabasesDrug Safety, 2018
- Methods for safety signal detection in healthcare databases: a literature reviewExpert Opinion on Drug Safety, 2017
- Electronic Health Data for Postmarket Surveillance: A Vision Not RealizedDrug Safety, 2015
- Illustration of the Weibull Shape Parameter Signal Detection Tool Using Electronic Healthcare Record DataDrug Safety, 2013
- Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARDPharmacoepidemiology and Drug Safety, 2010
- Temporal pattern discovery in longitudinal electronic patient recordsData Mining and Knowledge Discovery, 2009
- ROCR: visualizing classifier performance in RBioinformatics, 2005
- Using Smoothed Receiver Operating Characteristic Curves to Summarize and Compare Diagnostic SystemsJournal of the American Statistical Association, 1998